Objectives: To investigate the phenotypic effect of expression of selected acquired macrolide resistance genes (AMRGs) in non-typeable Haemophilus influenzae (NTHi).
Introduction
Most isolates of Haemophilus influenzae exhibit low-level intrinsic non-susceptibility to macrolide antibiotics, yet there is increasing use of macrolides for respiratory infections where non-typeable H. influenzae (NTHi) may be involved. 1, 2 While the efficacy of these agents in treating infections with WT NTHi has already been questioned, 2,3 the potential for NTHi to acquire high-level macrolide resistance may further undermine the utility of these agents.
High-level macrolide resistance in NTHi has historically been attributed to chromosomal alterations in 23S rRNA or the L4 and L22 ribosomal proteins. 4, 5 In one of the few studies where acquired macrolide resistance genes (AMRGs) have been reported in clinical isolates of NTHi, the effect of these genes on phenotypic resistance was inconsistent, with only 25% of the 106 erm-or mef-carrying isolates reported in the study exhibiting phenotypic resistance to macrolides. 6 A recent study has reported a clinical isolate of NTHi carrying mef(A) and exhibiting high-level macrolide resistance, with convincing evidence that the gene was responsible for the phenotype. 7 However, questions remain regarding whether erm genes are capable of producing a similar effect in NTHi. Therefore, the aim of this study was to investigate and clarify the phenotypic effect of expression of erm(A), erm(B) and erm(C) in NTHi.
Materials and methods

Cloning of erm genes into H. influenzae Rd
Selected erm genes [erm(A), erm(B) and erm(C)] were cloned into Escherichia coli JM109 using the EcoR1 site of the kanamycin resistancemarked shuttle vector pLS88. Inserts were constructed using PCR with EcoR1-tailed gene-specific primers on genomic DNA template from the isolates listed in Table 1 . Two inserts were prepared for each gene: one including the promoter region and natural leader sequence (LS) and one without. The presence of the respective erm genes in the resulting E. coli clones was confirmed using locked nucleic acid dual-labelled hydrolysis probes (Sigma-Aldrich, NSW, Australia) as previously described. 8 The cloned genes were subsequently amplified and sequenced to confirm identity and establish orientation using primers specific to the regions in pLS88 that flanked the EcoR1 site. The sequences have been deposited in GenBank (accession numbers KY848263-KY848268). Plasmid DNA from suitable clones was used to transform H. influenzae Rd using electroporation as previously described 9 and the presence of the respective genes was again confirmed using locked nucleic acid dual-labelled hydrolysis probes.
Macrolide susceptibility testing and expression analysis
Erythromycin and azithromycin MICs for the H. influenzae Rd transformants were determined by broth microdilution in accordance with CLSI recommendations and methodology. RNA extractions were performed on all H. influenzae Rd transformants using the RNeasy Mini Kit (Qiagen) followed by reverse transcription using the iScript TM cDNA Synthesis Kit (Bioline, NSW, Australia), with cDNA quantified using locked nucleic acid dual-labelled hydrolysis probes as previously described. 8 An inducer was not used to attempt to alter expression. gyrA was selected as the housekeeping gene (F primer, 5
0 -TCCAATCATCTATC ACCC-3 0 ; R primer, 5 0 -TTACATCACCCACAACAC-3 0 ; probe, 5 0 -TGCACGCCCAA CGATAACC-3 0 ) and DCT values were calculated using the formula DCT " 2 #[CT(GOI)#CT(gyrA)] (where GOI stands for gene of interest). Comparisons of DCT values were performed using unpaired t-tests.
Results and discussion
For this study, we were interested in observing the phenotypic effect of various erm genes in H. influenzae. Due to the variety and complexity of the conjugative elements that carry these genes naturally, we decided to use cloning techniques to transfer the genes into H. influenzae Rd as we believed that this would provide a better comparison of the effect of the genes. Previous unpublished observations have demonstrated that ORFs cloned into pLS88 in a 5 0 to 3 0 orientation (relative to the primers described above) are transcribed using promoters located upstream, and given the complexity of the regulatory regions of many AMRGs we initially chose to clone the AMRGs without the native promoters and LS so that the erm genes were transcribed using these upstream promoters.
The calculated DCT values for each of these 'no-LS' transformants were significantly increased compared with that of the untransformed H. influenzae Rd control [erm(A), P " 0.0047; erm(B), P " 0.0031; erm(C), P , 0.0001], for which no amplification occurred using the AMRG locked nucleic acid dual-labelled hydrolysis probes. This indicates that all genes were being expressed in H. influenzae.
Interestingly, when the DCT values of each transformant were compared with one another, the DCT values differed significantly (Figure 1) , indicating that the level of expression of each gene was not constant across the transformants despite being cloned into the same site on the same plasmid. These results were confirmed by a repeat experiment, using the same transformants, but fresh RNA isolation, cDNA generation and quantification, and are not easily explained. Of the erm genes included in this study, erm(A) did not appear to generate a large increase in MIC (erythromycin 16 mg/L; azithromycin 4 mg/L) compared with the untransformed H. influenzae Rd strain (erythromycin 8 mg/L; azithromycin 4 mg/L). By comparison, erm(B) (erythromycin 64 mg/L; azithromycin 32 mg/L) and erm(C) (erythromycin .64 mg/L; azithromycin .64 mg/L) were associated with much larger MIC increases. This is reflected by the differences in DCT values for these transformants, with the erm(A) transformant having significantly lower expression than that of the other erm transformants.
After this experiment, we then cloned each of these erm genes with their respective native promoters and LSs to determine whether any change in phenotype and expression level would be observed. DCT values were obtained for each of these new 'LS' transformants and compared with the corresponding no-LS transformants obtained in the first experiment. Of the three genes included in this study, the level of expression of the erm(B) transformant did not appear to be significantly different between the two pairs (P " 0.6186; Figure 1 ). When the erythromycin and azithromycin MICs were determined for the erm(B) LS transformant, no significant changes in the MICs (erythromycin .64 mg/L; azithromycin .64 mg/L) were apparent compared with the corresponding no-LS transformants, which is consistent with the findings of the expression analyses. However, the erm(C) LS transformant produced a significantly lower 
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DCT than the corresponding no-LS transformant (P " 0.0013; Figure 1 ). In the case of the erm(C) transformant, this drop in expression resulted in a corresponding decrease in erythromycin and azithromycin MICs (erythromycin 16 mg/L; azithromycin 4 mg/L) compared with the corresponding no-LS transformant.
The erm(A) LS transformant produced a significantly higher DCT than its corresponding no-LS transformant (P " 0.0097; Figure 1 ). In addition, a corresponding and significant increase in erythromycin and azithromycin MICs for the erm(A) LS transformant was observed (erythromycin .64 mg/L; azithromycin .64 mg/L). It is interesting to note that the level of expression of erm(A) required for the development of macrolide resistance appears to be greater than the level of expression of erm(B) and erm(C) required to give a similar outcome. This may indicate that erm(B) and erm(C) have greater efficiency in modifying the macrolide binding target site, although further investigations would be required to establish this. In any case, expression of all erm genes of interest and subsequent development of macrolide resistance in H. influenzae has been demonstrated in this study. In comparison with our results, the MICs observed in the study of Roberts et al. 6 were inconsistently raised for those isolates in which erm(A), erm(B) and erm(C) were detected. It is difficult to explain this; however, in the clinical isolates of the Roberts et al. 6 study, the genes were on native replicons. This may have produced different levels of expression, although this was not assessed in that study. In addition, L4 and L22 ribosomal protein genes were only sequenced in some of the erm-positive isolates and 23S rRNA was not sequenced in any isolates, so it is difficult to attribute any observed decreased macrolide susceptibility to the erm genes in those isolates where other known mechanisms were not excluded. 6 While we have been able to demonstrate that the expression of cloned erm(A), erm(B) and erm(C) genes in H. influenzae Rd produces macrolide resistance, it is still unclear how much of a threat these particular AMRGs pose to future treatment of infections involving NTHi. The study of Roberts et al. 6 remains the only study in which these genes have been reported in clinical isolates of NTHi, whereas isolates with high-level resistance due to chromosomal mutations are well established. 4 However, the existence of the chromosomal mutation pathway to resistance need not be a barrier to an alternative mechanism such as AMRG acquisition, even if these genes produce lower levels of resistance. The emergence of b-lactamase-negative, low-level ampicillin resistance mediated by altered PBP3 occured in H. influenzae well after the establishment of b-lactamase-mediated high-level resistance 11 and thus provides a similar precedent.
While chromosomal mutations remain the predominant macrolide resistance mechanism in NTHi, the potential role of these and other AMRGs in NTHi may warrant further monitoring in the future due to the potential for the acquisition and expression of these genes to cause reduced macrolide susceptibility, especially in light of the recent report of the isolation of a WT NTHi strain carrying mef(A) and exhibiting a high-level resistance phenotype. . DCT values for each of the three transformants without and with the LS (no LS versus LS) were also compared (right image). *P , 0.01, **P , 0.001 and ***P , 0.0001.
